Pregnancy News and Research

Latest Pregnancy News and Research

Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS

Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study showed the combination of Avastin® (bevacizumab) and chemotherapy followed by maintenance use of Avastin alone increased the time women with previously untreated advanced ovarian cancer lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone. A preliminary assessment of safety noted adverse events previously observed in pivotal trials of Avastin.

25 Feb 2010

Frozen/thawed ovarian tissue transplant: Woman has two children from separate pregnancies

For the first time, a woman has given birth to two children after her fertility was restored using transplants of ovarian tissue that had been removed and frozen during her cancer treatment and then restored once she was cured.

24 Feb 2010

Women who become pregnant with single foetus after IVF/ICSI have increased risk of stillbirth

Women who become pregnant with a single foetus after in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) have an increased risk of a stillbirth, according to new research out today (Wednesday).

24 Feb 2010

New report identifies enormous global impact of preterm birth and stillbirth

A new report issued today identifies the enormous global impact of preterm birth and stillbirth-and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000.

24 Feb 2010

INMA researchers study the consequences iodine supplements in pregnant women

Iodine is an essential element for synthesising thyroid hormones. A team of researchers from the Childhood and Environment Project has studied the consequences of pregnant women consuming it in their diet and in supplements. The results suggest the need to evaluate their iodine nutritional status before systematically recommending taking it during pregnancy.

24 Feb 2010

Avizent Benefit Re health benefits captive program available for self-funded employers

National claims and risk management service provider Avizent announced today the creation of an innovative health benefits captive program for self-funded employers.

24 Feb 2010

Research addresses preterm birth, stillbirth health issues, highlights preventive interventions

New research published in BMC Pregnancy and Childbirth notes some of the "serious short- and long-term health issues" associated with preterm births and identifies steps that can be taken to reduce the number of stillbirths and premature births worldwide, United Press International reports.

24 Feb 2010

SRI International awarded $3.8M BARDA contract to develop a radiation assessment device

SRI International, an independent nonprofit research and development institute, has received a $3.8M contract from the Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA). SRI will research and develop a device to triage individuals who may have been exposed to ionizing radiation after a radiological or nuclear incident.

24 Feb 2010

Forest Laboratories' Bystolic tablets for treatment of stable CHF failed to receive FDA approval

Forest Laboratories, Inc. announced today that the U.S. Food and Drug Administration did not approve the additional indication for Bystolic® (nebivolol) tablets as a treatment for stable chronic heart failure (CHF) as requested in the company’s Supplemental New Drug Application (sNDA).

23 Feb 2010

FDA grants Diagnostic Hybrids emergency use authorization for 2009 H1N1 Influenza A Virus ID Kit

Diagnostic Hybrids, a Quidel Company has received emergency use authorization from the U.S. Food and Drug Administration for its D3® UltraTM 2009 H1N1 Influenza A Virus ID Kit, a monoclonal antibody fluorescent staining kit for the specific identification of 2009 H1N1 influenza A in direct patient specimens or incubated tissue cultures.

23 Feb 2010

Prevention of preterm birth and stillbirth: Global collaborative efforts needed

A new report identifies the enormous global impact of preterm birth and stillbirth—and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000. Additionally, an estimated 3.2 million are stillborn each year, and many of these losses are linked to maternal deaths.

23 Feb 2010

Genentech's Avastin combination Phase III study in advanced stomach cancer does not meet primary endpoint

Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study (AVAGAST) did not meet its primary endpoint of showing Avastin® (bevacizumab) plus Xeloda® (capecitabine) or 5-FU and cisplatin chemotherapy extended the lives of people with inoperable or advanced stomach (gastric) cancer, compared to chemotherapy alone.

23 Feb 2010

Excessive weight gain during pregnancy linked to increased risk of gestational diabetes

Women who gain excessive weight during pregnancy, especially in the first trimester, may increase their risk of developing diabetes later in their pregnancy, according to a study by the Kaiser Permanente Division of Research that appears online in the current issue of Obstetrics and Gynecology.

23 Feb 2010

Global report identifies causes leading to preterm births and stillbirths

More research and attention are urgently needed to understand and reduce the incidence of preterm births and stillbirths worldwide, according to experts from the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS).

23 Feb 2010

Six scientists to study causes of preterm birth supported by funding from March Of Dimes

The March of Dimes has committed another $2.6 million to support the work of six scientists for the next three years as they study the causes of preterm birth. The 2010 grants bring the six-year total of the March of Dimes Prematurity Research Initiative grant program to more than $15 million.

23 Feb 2010

Black women are more prone to peripartum cardiomyopathy around childbirth time

A study examining the incidence of peripartum cardiomyopathy in women who gave birth at a Medical College of Georgia's teaching hospital between July 2003 and July 2008, showed that while 55 percent of the women were white, 93 percent of those who developed cardiomyopathy were black, said Dr. Mindy B. Gentry, an MCG cardiologist.

23 Feb 2010

AAN guideline evaluates drugs’ safety and efficacy for treatment of muscle cramps

A new guideline from the American Academy of Neurology recommends that the drug quinine, although effective, should be avoided for treatment of routine muscle cramps due to uncommon but serious side effects.

23 Feb 2010

Opinion: Violence against women, rebuilding Haiti, food security

"Violence against women is a global epidemic, threatening the lives and safety of women and girls around the world," Sen. Benjamin Cardin (D-Md.), chairman of the U.S. Helsinki Commission, writes in a Baltimore Sun opinion piece in which he asserts his support of the International Violence Against Women Act. In the piece, Cardin describes how violence against women increases risks of health problems - such as dying in pregnancy and contracting HIV - and poverty (2/19).

20 Feb 2010

Quidel acquires Diagnostic Hybrids for $130 million

Quidel Corporation, a leading provider of rapid diagnostic tests, has completed its previously announced acquisition of Diagnostic Hybrids, Inc. for approximately $130 million in cash.

20 Feb 2010

10th Annual Conference for Young Women Affected by Breast Cancer

Young women diagnosed with breast cancer are uniquely impacted by issues often not faced by older women. Breast cancer is often detected at later stages, increasing diagnoses of more advanced cancers. The impact of cancer treatment on fertility, body image, financial challenges, and slightly higher mortality rates are significant concerns for this population.

19 Feb 2010

Pregnancy News and Research

Latest Pregnancy News and Research

Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS

Frozen/thawed ovarian tissue transplant: Woman has two children from separate pregnancies

Women who become pregnant with single foetus after IVF/ICSI have increased risk of stillbirth

New report identifies enormous global impact of preterm birth and stillbirth

INMA researchers study the consequences iodine supplements in pregnant women

Avizent Benefit Re health benefits captive program available for self-funded employers

Research addresses preterm birth, stillbirth health issues, highlights preventive interventions

SRI International awarded $3.8M BARDA contract to develop a radiation assessment device

Forest Laboratories' Bystolic tablets for treatment of stable CHF failed to receive FDA approval

FDA grants Diagnostic Hybrids emergency use authorization for 2009 H1N1 Influenza A Virus ID Kit

Prevention of preterm birth and stillbirth: Global collaborative efforts needed

Genentech's Avastin combination Phase III study in advanced stomach cancer does not meet primary endpoint

Excessive weight gain during pregnancy linked to increased risk of gestational diabetes

Global report identifies causes leading to preterm births and stillbirths

Six scientists to study causes of preterm birth supported by funding from March Of Dimes

Black women are more prone to peripartum cardiomyopathy around childbirth time

AAN guideline evaluates drugs’ safety and efficacy for treatment of muscle cramps

Opinion: Violence against women, rebuilding Haiti, food security

Quidel acquires Diagnostic Hybrids for $130 million

10th Annual Conference for Young Women Affected by Breast Cancer

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Pregnancy News and Research

Latest Pregnancy News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in